Home >> WEBINARS >> Respectability in stage III NSCLC:
Case-based considerations for clinical decision making

Respectability in stage III NSCLC:
Case-based considerations for clinical decision making

Print Friendly, PDF & Email

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Webinar presenters Michael Walker, MD, System Chief, Thoracic Surgery, Medical Director, Cancer Program, Main Line Health, and Tracey Evans, MD, Director, Thoracic Oncology Research, Co-Director, Thoracic Oncology Program, Associate Program Director, Hematology/Medical Oncology Fellowship Program, Lankenau Cancer Center, discuss AJCC staging guidelines for lung cancer, specifically Stage III disease. This on-demand webinar originally broadcast on November 14, 2018.

CAP TODAY does not endorse any of the products or services named within.
©2018 AstraZeneca. All rights reserved. US-23324 Last Updated 9/18

x

Check Also

Current and emerging biomarkers: science, technologies, and practicalities

Webinar presenter Tabetha Sundin, PhD, HCLD, MB, discusses the crucial role pathologists play in furthering advancements that may help predict which patients are likely to benefit from immuno-oncology therapies. This webinar will empower you to understand the biology behind current and emerging immuno-oncology biomarkers. This on-demand webinar originally broadcast on October 3, 2018.

X